FPN || Gastroenterology

Novel noninvasive therapy for extraesophageal reflux

Posted on: 10/06/2014 - 14:15

CHICAGO – A novel, externally worn device for the treatment of extraesophageal reflux proved effective, safe, and well tolerated in a multicenter clinical trial. "Given the poor response to...

Field of Interest: Gastroentero...

Type: News Item

Diet modifications highly effective in EoE

Posted on: 01/06/2014 - 05:01

An elemental diet was more than 90% effective in inducing histologic remission in eosinophilic esophagitis patients, reported Dr. Ángel Arias and colleagues in the June issue of...

Field of Interest: Gastroentero...

Type: News Item

Phone calls offer ‘early warning’ in IBD

Posted on: 01/06/2014 - 05:01

Inflammatory bowel disease patients rely on phone communication as much as or more than doctor visits for management of their disease, and heavier reliance may be a sign of impending emergency...

Field of Interest: Gastroentero...

Type: News Item

Less risk of esophageal bleed with rifaximin

Posted on: 30/05/2014 - 19:20

CHICAGO – Patients with cirrhosis and medium to large esophageal varices were 81% less likely to develop a first esophageal variceal bleed within 5 years if they took rifaximin to manage hepatic...

Field of Interest: Gastroentero...

Type: News Item

FISH panel may improve Barrett’s surveillance

Posted on: 28/05/2014 - 17:45

CHICAGO – Fluorescence in situ hybridization testing for aneuploidy and loss of the tumor suppressor gene P16 can be useful in predicting progression to high-grade dysplasia and adenocarcinoma in...

Field of Interest: Gastroentero...

Type: News Item

Risk alleles linked to thiopurine-induced pancreatitis

Posted on: 27/05/2014 - 19:45

CHICAGO – A genomewide association study has identified specific alleles that may pinpoint those at risk for thiopurine-induced pancreatitis in inflammatory bowel disease. Patients heterozygous at...

Field of Interest: Gastroentero...

Type: News Item

Integrin receptor antagonist approved for IBD, with postmarketing safety plans

Posted on: 20/05/2014 - 23:25

Vedolizumab, an integrin receptor antagonist, has been approved as a treatment for moderate to severe inflammatory bowel disease in adults who have not had an adequate response to one or more...

Field of Interest: Gastroentero...

Type: News Item

Fecal transplant falls short in UC, but may not be the end

Posted on: 20/05/2014 - 22:35

CHICAGO – Results were negative from the first randomized placebo-controlled trial of fecal microbiota transplant in ulcerative colitis, but enthusiasm remains for this newly regulated and trendy...

Field of Interest: Gastroentero...

Type: News Item

Insulin perturbations seen in nondiabetic patients with NAFLD

Posted on: 18/05/2014 - 15:45

LAS VEGAS – Nondiabetic patients with nonalcoholic fatty liver disease already have insulin perturbations putting them on track for a variety of more serious health conditions, new data show. In a...

Field of Interest: Gastroentero...

Type: News Item

Insulin perturbations seen in nondiabetic patients with NAFLD

Posted on: 18/05/2014 - 15:45

Field of Interest: Endocrinology

Type: News Item

« first
‹ previous
…
10
11
12
13
14
15
16
17
18

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters